Cargando…
Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice
Combined checkpoint blockade (e.g., PD1/PD-L1) with traditional clinical therapies can be hampered by side effects and low tumour-therapeutic outcome, hindering broad clinical translation. Here we report a combined tumour-therapeutic modality based on integrating nanosonosensitizers-augmented noninv...
Autores principales: | Yue, Wenwen, Chen, Liang, Yu, Luodan, Zhou, Bangguo, Yin, Haohao, Ren, Weiwei, Liu, Chang, Guo, Lehang, Zhang, Yifeng, Sun, Liping, Zhang, Kun, Xu, Huixiong, Chen, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497709/ https://www.ncbi.nlm.nih.gov/pubmed/31048681 http://dx.doi.org/10.1038/s41467-019-09760-3 |
Ejemplares similares
-
Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy
por: Lin, Xiaoning, et al.
Publicado: (2021) -
Autophagy blockade synergistically enhances nanosonosensitizer-enabled sonodynamic cancer nanotherapeutics
por: Zhou, Liqiang, et al.
Publicado: (2021) -
Emerging nanosonosensitizers augment sonodynamic-mediated antimicrobial therapies
por: Xu, Qinglin, et al.
Publicado: (2023) -
Ultrasound-Controlled CRISPR/Cas9 System Augments
Sonodynamic Therapy of Hepatocellular Carcinoma
por: Yin, Haohao, et al.
Publicado: (2021) -
Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics
por: Huang, Ju, et al.
Publicado: (2018)